RankAlpha logo
Back to Rankings

REGN

RegeneronC
Nasdaq / Pharmaceuticals, Biotechnology & Life Sciences
Last Price
At close
2026-07-18
View Chart
Current thesis
The near-term bull case is that the Q1 print still showed strong underlying earnings power: revenue grew 19%, Dupixent profit share accelerated, Libtayo remained strong, and EYLEA HD demand grew despite inventory and pricing friction. The packet's trusted-news set framed the quarter as an earnings beat, but detailed T+1 analyst estimate and target revisions were not available, so this is supportive rather than decisive evidence.
Posture
Mixed
Lead driver
Value
What changed
Value remains the lead driver in the composite, 7D delta -0.4.
What can break
EYLEA franchise erosion remains the main risk, with management warning that additional U.S. biosimilar competition is expected in the second half of 2026. [#10-Q-2026-04-29]
Momentum
22
Value
65
Sentiment
60
Setup hits (3d)
0 · Net Neutral
AI TargetsBase $780.00 · Bull $880.00 · Bear $620.00
Data freshness
Prices
As of 2026-07-18
Fundamentals
As of 2026-07-17 • Vendor: Data Vendor v1
Scores
As of 2026-07-18 • Model: HYBRID_IC_RP
AI Memo
As of 2026-04-29 • Model: RankAlpha Sentiment Codex
Investment thesis
As of 2026-07-18
Supporting evidence
What
Grade C · Mixed
Confidence Medium · Net Neutral
Target $825.00
Why
Momentum22 · Δ7d +17.9
Value65 · Δ7d -0.4
Sentiment60 · Δ7d -5.6
So what
Balanced signals (Net Neutral). Wait for confirmation before sizing up.
Lead driver: Value · See fundamentals
Momentum
22
26% active weight
Current posture
7d trendImproving
Δ7d
+17.9
Δ21d
+20.9
Value
65
39% active weight
Current posture
7d trendFlat
Δ7d
-0.4
Δ21d
-0.4
Sentiment
60
34% active weight
Current posture
7d trendSoftening
Δ7d
-5.6
Δ21d
-8.6
Why this grade

Composite grade C. Momentum 22.1 / Value 65.4 / Sentiment 59.5

Fundamentals (TTM)
As of 2026-07-17
Market Cap
$70.94B
Beta
0.40
Shares Out
104.84M
P/E (TTM)
18.1
P/S (TTM)
5.63
P/FCF (TTM)
22.26
Rev YoY
+19.0%
EPS YoY
-7.2%
Gross Margin
+80.9%
Op Margin
+25.9%
Net Debt
-$5.64B
Current Ratio
3.56
As of 2026-07-18 • Updated nightlySource: Internal modelMethodology